Open AccessEdaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of Study 19 (MCI186-19) [clinical trial NCT01492686]
Author(s) -
Benjamin Rix Brooks,
Terry HeimanPatterson,
Martina WiedauPazos,
X. Shawn Liu,
Jeffrey Zhang,
Stephen Apple
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0258614
Subject(s) - edaravone , amyotrophic lateral sclerosis , medicine , post hoc analysis , placebo , vital capacity , post hoc , anesthesia , diffusing capacity , pathology , lung function , alternative medicine , disease , lung
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom